OPK Opko Health Inc

Price (delayed)

$3.61

Market cap

$2.42B

P/E Ratio

19

Dividend/share

N/A

EPS

$0.19

Enterprise value

$2.62B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

The net income has soared by 141% year-on-year
Opko Health's EPS has soared by 140% YoY
The debt has increased by 7% YoY
Opko Health's gross margin has decreased by 2.4% from the previous quarter

Key stats

What are the main financial stats of OPK
Market
Shares outstanding
670.15M
Market cap
$2.42B
Enterprise value
$2.62B
Valuations
Price to earnings (P/E)
19
Price to book (P/B)
1.43
Price to sales (P/S)
1.31
EV/EBIT
16.38
EV/EBITDA
10.76
EV/Sales
1.48
Earnings
Revenue
$1.77B
EBIT
$159.64M
EBITDA
$242.93M
Free cash flow
$71.88M
Per share
EPS
$0.19
Free cash flow per share
$0.11
Book value per share
$2.53
Revenue per share
$2.76
TBVPS
$2.16
Balance sheet
Total assets
$2.52B
Total liabilities
$823.06M
Debt
$285.3M
Equity
$1.7B
Working capital
$195.12M
Liquidity
Debt to equity
0.17
Current ratio
1.48
Quick ratio
1.01
Net debt/EBITDA
0.81
Margins
EBITDA margin
13.7%
Gross margin
36.8%
Net margin
6.8%
Operating margin
7.7%
Efficiency
Return on assets
5%
Return on equity
7.3%
Return on invested capital
14%
Return on capital employed
7.5%
Return on sales
9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPK stock price

How has the Opko Health stock price performed over time
Intraday
-2.43%
1 week
1.98%
1 month
-16.82%
1 year
37.79%
YTD
-8.61%
QTD
-15.85%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$1.77B
Gross profit
$651.45M
Operating income
$136.91M
Net income
$120.8M
Gross margin
36.8%
Net margin
6.8%
The operating income has soared by 157% YoY and by 137% from the previous quarter
The net income has soared by 141% year-on-year
OPK's operating margin has soared by 129% year-on-year and by 93% since the previous quarter
The net margin has soared by 121% YoY

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
19
P/B
1.43
P/S
1.31
EV/EBIT
16.38
EV/EBITDA
10.76
EV/Sales
1.48
Opko Health's EPS has soared by 140% YoY
The P/B is 11% below the last 4 quarters average of 1.6 and 4.7% below the 5-year quarterly average of 1.5
Opko Health's equity has increased by 10% YoY
The company's revenue has surged by 99% YoY and by 23% QoQ
The P/S is 50% below the 5-year quarterly average of 2.6 and 31% below the last 4 quarters average of 1.9

Efficiency

How efficient is Opko Health business performance
OPK's ROIC has soared by 155% year-on-year and by 122% since the previous quarter
The ROE has soared by 141% YoY
The ROA has soared by 140% YoY
Opko Health's ROS has soared by 130% YoY and by 84% from the previous quarter

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
Opko Health's quick ratio has increased by 49% YoY and by 6% from the previous quarter
Opko Health's current ratio has increased by 32% YoY and by 6% from the previous quarter
The debt is 83% lower than the equity
Opko Health's equity has increased by 10% YoY
The debt has increased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.